Hello all, wanted to see how many institutions are considering any MDI/DPI/Inhaler therapy as an aerosol generating device for your COVID-19 patients. Would like to see what the community is doing as the question brought forth by IP as we place COVID-19 patients receiving aerosol generating therapies in negative pressure rooms. The issue is when we have a patient receiving LABA/LAMA/ICS daily or twice daily and thus requiring a negative pressure room. Due to the demand for the rooms it seems reasonable to not consider this a "continuous" aerosol generating device. I appreciate your thoughts and input. Thank you.